IPO Issue Details
Issue Price / Price Band₹97 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,200 Shares per Lot
Total Issue Size44,49,600 shares (aggregating up to ₹43.16 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenWed, 15 May 2024
Subscription CloseFri, 17 May 2024
Anchor AllotmentTue, 14 May 2024
Basis of AllotmentTue, 21 May 2024
Initiation of RefundsWed, 22 May 2024
Credit of Shares to DematWed, 22 May 2024
Listing DateThu, 23 May 2024
UPI Mandate Deadline2024-05-17
Application & Investment Details
Retail — Min (1 Lots)₹1,16,400 — 1,200 shares
Retail — Max (13 Lots)₹1,513,200 (13 Lots)
HNI — Min (2 Lots)₹2,32,800 — 2,400 shares
EPS (Pre-IPO)₹4.21
EPS (Post-IPO)₹6.31
P/E Ratio (Pre-IPO)23.03x
P/E Ratio (Post-IPO)15.38x
Net Offer to Public42,21,600 shares (aggregating up to ₹40.95 Cr)
Reserved for Market Maker2,28,000 shares (aggregating up to ₹2.21 Cr)
Pre-IPO Promoter Holding1,19,37,600 shares
Post-IPO Promoter Holding1,63,87,200 shares
About Quest Laboratories Ltd
Incorporated in June 1998, Quest Laboratories Limited is a pharmaceutical company manufacturing a range of antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more.The company operates in the domestic market across twelve (12) states and two (2) union territories. These include Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, Jharkhand, Assam, Karnataka, Jammu & Kashmir, Rajasthan, West Bengal, Gujarat, Telangana, Haryana, and Bihar.The manufacturing unit of the company is located in Dhar, Madhya Pradesh.The company holds WHO Schedule M GMP and GLP certifications, as well as ISO/IEC 17025:2017 and ISO 9001:2015 certifications.By December 31st, 2023, the company employs 83 individuals to lookafter various aspects of its manufacturing operations, including production, quality control, technical and engineering support services, inventory management, administration, accounting, and other functions such as storage, packing, and dispatch.
Objects of the Issue
Quest Laboratories Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Funding of capital expenditure towards purchase of plant and machinery for expansion at the existing manufacturing facility;
2
Funding working capital requirements of the company;
3
Funding working capital requirements of the company;
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,19,37,600 shares
Post-IPO Promoter Holding
1,63,87,200 shares